Cannabis Cognitive Effects Are Small and Largely Disappear After 72 Hours of Abstinence
Association of cannabis with cognitive functioning in adolescents and young adults: A systematic review and meta-analysis
Bottom Line
A meta-analysis of 69 studies found that cannabis-related cognitive deficits (d=-0.25) become statistically non-significant after 72 hours of abstinence, suggesting most measured impairment is residual drug effect rather than lasting damage.
Why It Matters
For years, the narrative was that cannabis damages young brains — period. This meta-analysis didn't refute that concern entirely, but it substantially complicated the story. The effect sizes were small, not the dramatic deficits often implied in public health messaging. And the abstinence finding suggested the brain recovers more than the scare campaigns implied. This matters for policy, for parents, and for young people themselves. There's a difference between "cannabis causes small, mostly reversible cognitive effects" and "cannabis permanently damages your brain." Both justify caution, but only one is what the data actually showed.
The Backstory
Every study about cannabis and the brain seems to deliver bad news. Memory impairment. Attention deficits. Slower processing speed. Lower IQ. The cumulative impression from decades of research is grim: cannabis damages cognitive function, and the damage stacks up over time.
In 2018, J. Cobb Scott assembled all of it — 69 studies, over 8,700 participants — and asked the question everyone had been avoiding: how much of the cognitive deficit is actually the drug still in your system, and how much persists after it clears?
The answer changed the conversation.
The Meta-Analysis
Scott's team at the University of Pennsylvania reviewed every peer-reviewed study examining cannabis and cognitive functioning in adolescents and young adults (mean age 26 and under) published through May 2017. They found 69 studies meeting their inclusion criteria, encompassing 2,152 cannabis users and 6,575 comparison participants with minimal cannabis exposure.
They classified cognitive outcomes into ten domains — learning, memory, attention, processing speed, perceptual motor function, language, executive function, psychomotor function, delayed memory, and complex cognition — and calculated effect sizes using multivariate mixed-effects models.
The headline finding: when you look at all 69 studies together, cannabis users show a small cognitive deficit (d = -0.25) compared to non-users. That's real, but it's small — roughly equivalent to the cognitive difference between someone who got a good night's sleep and someone who got a mediocre one.
But here's what mattered.
The 72-Hour Threshold
Scott separated the studies into two groups: those that required participants to abstain from cannabis for at least 72 hours before cognitive testing (15 studies, n = 928), and those with less stringent or no abstinence requirements (54 studies, n = 7,799).
The cognitive deficits associated with cannabis use were not significantly different from zero after 72 hours of abstinence. Three days. That's all it took for the measurable cognitive gap between cannabis users and non-users to become statistically undetectable.
This didn't mean that every dimension of cognition recovered perfectly in every person after three days. It meant that across the aggregate of studies, the effect was small enough to be indistinguishable from random variation. The implication was explosive: most of what prior studies had measured as "cannabis-related cognitive impairment" was actually residual drug effect — THC still active in the brain — not lasting damage.
What This Means (and What It Doesn't)
Key Takeaways
The study's own authors were careful to state what their findings did and didn't show. They wrote that their results "indicate that previous studies of cannabis in youth may have overstated the magnitude and persistence of cognitive deficits associated with use" and that "reported deficits may reflect residual effects from acute use or withdrawal."
But they also emphasized limitations. The 15 studies with 72+ hours of abstinence had smaller samples and may have been underpowered to detect subtle persistent effects. The meta-analysis couldn't assess very long-term users or distinguish between adolescent-onset and adult-onset use in its abstinence analysis. And it examined cognition only — not academic achievement, occupational functioning, or psychiatric outcomes.
The Nuance: Not Everyone Recovers Equally
The most important caveat comes from other research, not from the Scott meta-analysis itself. The Meier 2012 Dunedin study found that persistent adolescent-onset cannabis users showed cognitive deficits that did not fully resolve after quitting — even at age 38. The Albaugh 2021 IMAGEN study showed accelerated prefrontal cortical thinning in adolescent users.
The resolution: the Scott findings likely apply most strongly to adult-onset or moderate users. For heavy adolescent-onset users — particularly those who used daily for years during the developmental window — recovery may be slower, less complete, or contingent on longer abstinence periods than 72 hours.
Why This Study Matters
For someone contemplating quitting cannabis — or sitting in the first miserable week of brain fog and sluggish thinking — the Scott meta-analysis delivers a message worth hearing: the cognitive impairment you're experiencing is almost certainly temporary.
The brain fog lifts. Memory comes back. Attention sharpens. The fog you're in right now is the drug leaving your system, not evidence of permanent damage. For most people, cognitive function is essentially normalized within days to weeks — and continues improving over the first month.
This is consistent with the CB1 receptor recovery data: receptors begin returning to normal density within 48 hours and are essentially back to baseline by 28 days. When the receptors recover, the functions they regulate recover with them.
The Researcher
J. Cobb Scott is an assistant professor of psychiatry at the University of Pennsylvania's Perelman School of Medicine and a staff psychologist at the Philadelphia VA Medical Center. His research focuses on the cognitive neuroscience of psychiatric disorders and substance use, with particular emphasis on cannabis and its effects on the developing brain. He co-directs the VA's Neuropsychology Postdoctoral Residency and has published over 50 research articles.
“Previous studies of cannabis in youth may have overstated the magnitude and persistence of cognitive deficits associated with use. Reported deficits may reflect residual effects from acute use or withdrawal.”
— J. Cobb Scott
University of Pennsylvania, Perelman School of Medicine
From the study's conclusions in JAMA Psychiatry, 2018
Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis
Scott JC, Slomiak ST, Jones JD, Rosen AFG, Moore TM, Gur RC () · JAMA Psychiatry
Frequently Asked Questions
Cite this study
Scott, J. Cobb; Slomiak, Samantha T.; Jones, Jason D.; Rosen, Adon F.G.; Moore, Tyler M.; Gur, Ruben C.. (2018). Association of cannabis with cognitive functioning in adolescents and young adults: A systematic review and meta-analysis. JAMA Psychiatry, 75(6), 585-595.